Amyloid-β-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the A peptide. Implications for the pathogenesis of Alzheimer's disease

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Dinamarca, Margarita C ^a   Sagal, Juan P ^a   Quintanilla, Rodrigo A ^a   Godoy, Juan A ^a   Arrzola, MacArena S ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CALCIUM; DIZOCILPINE; LITHIUM; LITHIUM CHLORIDE; WNT PROTEIN; WNT7A PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; HIPPOCAMPUS; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NEURITE; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; RAT;

RATTUS;

EID: 77249136019     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-4     Document Type: Article

References (46)

1. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. J Hardy DJ Selkoe, Science 2002 297 353 356 10.1126/science.1072994 12130773
2. Pathways towards and away from Alzheimer's disease. MP Mattson, Nature 2004 430 631 9 10.1038/nature02621 15295589
3. Amyloid-cholinesterase interactions. Implications for Alzheimer's disease. NC Inestrosa MC Dinamarca A Alvarez, FEBS J 2008 275 625 32 10.1111/j.1742-4658.2007.06238.x 18205831
4. Acetylcholinesterase accelerates assembly of amyloid - peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. NC Inestrosa A Alvarez CA Perez RD Moreno M Vicente C Linker OI Casanueva C Soto J Garrido, Neuron 1996 16 881 891 10.1016/S0896-6273(00)80108-7 8608006
5. Laminin affects polymerization, depolymerization and neurotoxicity of A peptide. C Morgan MP Bugueno J Garrido NC Inestrosa, Peptides 2002 23 1229 1240 10.1016/S0196-9781(02)00058-X 12128080
6. Colocalization of cholinesterase with -amyloid protein in aged and Alzheimer's brains. MA Moran EJ Mufson P Gomez-Ramos, Acta Neuropathol 1993 85 362 369 10.1007/BF00334445 8480510
7. Cholinergic Systems and related neuropathological predilection partners in AD. C Geula MM Mesulam, Alzheimer Disease New York: Raven Press 1993 263 291
8. Acetylcholinesterase promotes the aggregation of amyloid - peptide fragments by forming a complex with the growing fibrils. A Alvarez C Opazo R Alarcon J Garrido NC Inestrosa, J Mol Biol 1997 272 348 361 10.1006/jmbi.1997. 1245 9325095
9. Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. MA Chacon AE Reyes NC Inestrosa, J Neurochem 2003 87 195 204 10.1046/j.1471-4159.2003.01985.x 12969266
10. Acetylcholinesterase-A complexes are more toxic than A fibrils in rat hippocampus: effect on rat -amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. AE Reyes MA Chacon MC Dinamarca W Cerpa C Morgan NC Inestrosa, Am J Pathol 2004 164 2163 74 15161650
11. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. T Rees A Berson E Sklan L Younkin S Younkin S Brimijoin H Soreq, Curr Alzheimer Res 2005 2 291 300 10.2174/1567205054367847 15974894
12. -Amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. AY Abramov L Canevari M Duchen, J Neurosci 2004 24 565 75 10.1523/JNEUROSCI.4042- 03.2004 14724257
13. Calcium signals induced by amyloid - peptide and their consequences in neurons and astrocytes in culture. AY Abramov L Canevari MR Duchen, Biochim Biophys Acta 2004 1742 81 87 10.1016/j.bbamcr.2004.09.006 15590058
14. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. FM LaFerla, Nat Rev Neurosci 2002 3 862 872 10.1038/nrn960 12415294
15. -Amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. CS Casley JM Land MA Sharpe JB Clark MR Duchen L Canevari, Neurobiol Dis 2002 10 258 267 10.1006/nbdi.2002.0516 12270688
16. Amyloid- peptide induces cytochrome c release from isolated mitochondria. HS Kim JH Lee JP Lee EM Kim KA Chang CH Park. et al. Neuroreport 2002 13 1989 1993 10.1097/00001756-200210280-00032 12395106
17. Soluble -amyloid 1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. F Roselli M Tirard J Lu P Hutzler P Lamberti P Livrea M Morabito OF Almeida, J Neurosci 2005 25 11061 70 10.1523/JNEUROSCI.3034-05.2005 16319306
18. -Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. MP Mattson B Cheng D Davis K Bryant I Lieberburg RE Rydel, J Neurosci 1992 12 376 89 1346802
19. Peroxisomal proliferation protects from -amyloid neurodegeneration. MJ Santos RA Quintanilla A Toro R Grandy MC Dinamarca JA Godoy NC Inestrosa, J Biol Chem 2005 280 41057 68 10.1074/jbc.M505160200 16204253
20. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: Functional consequences. T Milakovic RA Quintanilla GV Johnson, J Biol Chem 2006 281 34785 95 10.1074/jbc.M603845200 16973623
21. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. MW Ward AC Rego BG Frenguelli DG Nicholls, J Neurosci 2000 20 7208 7219 11007877
22. The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. NC Inestrosa EM Toledo, Mol Neurodegener 2008 24 3 9 10.1186/1750-1326-3-9
23. Wnt7-a modulate the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. W Cerpa JA Godoy I Alfaro GC Farias MJ Metcalfe R Fuentealba C Bonasco NC Inestrosa, J Chem Biol 2008 29 591 5927
24. Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. GC Farias IE Alfaro W Cerpa CP Grabowsky JA Godoy C Bonasco NC Inestrosa, J Biol Chem 2009 284 15857 66 10.1074/jbc.M808986200 19332546
25. Structure-function implications in Alzheimers disease: effects of A oligomers at central synapses. W Cerpa MC Dinamarca NC Inestrosa, Curr Alzheimer s Res 2008 5 233 43 10.2174/156720508784533321 (Pubitemid 351840275)
26. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide. C Haass DJ Selkoe, Nat Rev Mol Cell Biol 2007 8 101 12 10.1038/nrm2101 17245412
27. Amyloid- protein dimers isolated directly from Alzheimer s brain impair plasticity and memory. GM Shankar S Li TH Mehta A Garcia-Mũoz NE Shepardson I Smith FM Brett. et al. Nat Med 2008 14 837 42 10.1038/nm1782 18568035
28. Different conformations of amyloid induce neurotoxicity by distinct mechanisms in human cortical neurons. A Deshpande E Mina C Glabe J Busciglio, J Neurosci 2006 26 6011 8 10.1523/JNEUROSCI.1189-06.2006 16738244
29. 2+ homeostasis, A levels and Alzheimer s disease risk. U Dress-Werringloer JC Lambert V Vingtdeux H Zhao H Vais A Siebert A Jan, et al. Cell 2008 133 1149 1161 10.1016/j.cell.2008.05. 048 18585350
30. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. SL Chan M Mayne CP Holden JD Geiger MP Mattson, J Biol Chem 2000 275 18195 18200 10.1074/jbc.M000040200 10764737
31. The amyloid -protein of Alzheimer's disease increase acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. G Sberna J Saez-Valero K Beyreuter CL Master DH Small, J Neurochem 1997 69 1177 1184 9282941
32. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 trasgenic mice occurs prior to amyloid plaque deposition. LR Fodero J Saez-Valero CA McLean RN Martins K Beyreuther CL Masters A Robertson DH Small, J Neurochem 2002 81 441 448 10.1046/j.1471-4159.2002.00902.x 12065653
33. Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid -peptide. J Saez-Valero ML de Ceballos DH Small C de Felipe, Neurosc Lett 2002 325 199 202 10.1016/S0304-3940(02)00282-3 (Pubitemid 34603529)
34. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J Saez-Valero G Sberna CA McLean DH Small, J Neurochem 1999 72 1600 1608 10.1046/j.1471-4159.1999.721600.x 10098867
35. Mitochondrial permeability transition and calcium dynamics in striatal neurons upon intense NMDA receptor activation. CC Alano G Beutner RT Dirksen RA Gross SS Sheu, J Neurochem 2002 80 531 538 10.1046/j.0022-3042.2001.00738.x 11905998
36. The pathophysiology of mitochondrial cell death. DR Green G Kroemer, Science 2004 305 626 629 10.1126/science.1099320 15286356
37. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. SL Budd DG Nicholls, J Neurochem 1996 67 2282 2291 8931459
38. Peroxisome proliferator-activated receptor is expressed in hippocampal neurons and its activation prevents -amyloid neurodegeneration: Role of Wnt signaling. NC Inestrosa JA Godoy RA Quintanilla CS Koenig M Bronfman, Exp Cell Res 2005 304 91 104 10.1016/j.yexcr.2004.09.032 15707577
39. Trolox and 17-estradiol protect against amyloid -peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. RA Quintanilla FJ Munoz MJ Metcalfe M Hitschfeld G Olivares JA Godoy NC Inestrosa, J Biol Chem 2005 280 11615 25 10.1074/jbc.M411936200 15659394
40. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. R Hashimoto C Hough T Nakazawa T Yamamoto DM Chuang, J Neurochem 2002 80 589 597 10.1046/j.0022-3042.2001.00728.x 11841566
41. Lithium desensitize mitochondria to calcium, antagonize permeability transition and diminish cytochrome C release. N Shalbuyeva T Brustovetsky N Brustovetsky, Biol Chem 2007 282 18057 18068 10.1074/jbc.M702134200 (Pubitemid 47100223)
42. From benefit to damage. Glutamate and avanced glycation end products in Alzheimer brain. P Riederer S Hoyer, J Neural Transm 2006 113 1671 1677 10.1007/s00702-006-0591-6 17053873
43. A 24-week open-label extension study of memantine in moderate to severe Alzheimer's disease. B Reisberg R Doody A Stoffler F Schmitt S Ferris HJ Möbius, Arch Neurol 2006 63 49 54 10.1001/archneur.63.1.49 16401736
44. Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. NC Inestrosa WL Roberts TL Marshall TL Rosenberry, J Biol 1987 262 4441 444
45. Hyperforin prevents -amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid - deposits. MC Dinamarca W Cerpa J Garrido JL Hancke NC Inestrosa, Mol Psychiatry 2006 11 1032 48 10.1038/sj.mp.4001866 16880827
46. Relationship between superoxide levels and delayed calcium deregulation in cultures cerebellar granule cells exposed continuously to glutamate. S Vesce L Kirk DG Nicholls, J Neurochem 2004 90 683 693 10.1111/j.1471-4159.2004.02516.x 15255947